1. Market Research
  2. > Media
  3. > Publishing Market Trends
  4. > Ventorlin Expectorant-Drug Insights,2014

DelveInsight’s pharmaceuticals report, “Ventorlin Expectorant - Drug Insights, 2014” provides Ventorlin Expectorant marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope
- A review of the Ventorlin Expectorant based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Ventorlin Expectorant on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2011-2015
- Qualitative and quantitative assessment of market space
- SWOT Analysis

Reasons to buy
- Evaluate the marketing status and exclusivity details of Ventorlin Expectorant to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Ventorlin Expectorant.
- API intelligence over Ventorlin Expectorant and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis of Ventorlin Expectorant.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2011-2015

Table Of Contents

Ventorlin Expectorant-Drug Insights,2014
- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for the Europe
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables
- Ventorlin Expectorant, Market, Global Sales (in USD), 2014
- Ventorlin Expectorant, Description
- Ventorlin Expectorant, Marketed Details the United States (US)
- Ventorlin Expectorant, Marketed Details the Europe (EU)
- Ventorlin Expectorant, Patent/Exclusivity Expiry (Year), 2014
- Ventorlin Expectorant, Patent Number Specific Patent Expiry (Year), 2014
- Ventorlin Expectorant, Patent Details
- Ventorlin Expectorant, Route of Synthesis
- Ventorlin Expectorant, the United States Drug Master File (US DMF), 2014
- Ventorlin Expectorant, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
- Ventorlin Expectorant, the API Manufacturers, China, 2014
- Ventorlin Expectorant, the API Manufacturers, India, 2014
- Ventorlin Expectorant, the API Manufacturers by the US DMF Status, 2014
- Ventorlin Expectorant, the API Manufacturers by Region, 2014
- Ventorlin Expectorant, the API Manufacturers by Location/Countries, 2014
- Ventorlin Expectorant, Generic Players, 2014
- Ventorlin Expectorant, Pipeline Drug Details, 2014
- Ventorlin Expectorant, Clinical Trials, 2014
- Ventorlin Expectorant, Clinical Trials by Zone, 2014
- Company Overview, 2014
- Ventorlin Expectorant, SWOT Analysis, 2014
- Phase III Pipeline Therapeutics, 2014

List of Figures
- Ventorlin Expectorant, Market, Global Sales (in million USD), 2014
- Ventorlin Expectorant, Global Sales % Change, 2014
- Ventorlin Expectorant, Patent/Exclusivity Expiry (Year), 2014
- Ventorlin Expectorant, Patent Number Specific Patent Expiry (Year), 2014
- Ventorlin Expectorant, Route of synthesis
- Ventorlin Expectorant, the API Manufacturers by the US DMF Status (%), 2014
- Ventorlin Expectorant, the API Manufacturers by Region, 2014
- Ventorlin Expectorant, the API Manufacturers by Location/Countries, 2014
- Ventorlin Expectorant, Generic Players, 2014
- Ventorlin Expectorant, Clinical Trials by Zone (%), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Malt-based Ingredients: Global Market Intelligence (2011-2020)

Malt-based Ingredients: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Malt-based Ingredients: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, form, grade, application ...

Fermentation Ingredients: Global Market Intelligence (2011-2020)

Fermentation Ingredients: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Fermentation Ingredients: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, application, and geography. ...

Rendered Products: Global Market Intelligence (2011-2020)

Rendered Products: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Rendered Products: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, source, application, and geography. ...

Media Global Market Report 2017

December 2016 $ 4000

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.